Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Migraine

Free Subscription 24.11.2025 5 Cephalalgia 3 Headache 1 Lancet Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cephalalgia

1. PARDO K, Schwedt TJ, Cutrer FM, Chiang CC, et al
   The promise of artificial intelligence and machine learning for migraine treatment outcome prediction: A narrative review.
   Cephalalgia. 2025;45:3331024251395541.
   PubMed         Abstract available
   
   
2. ORNELLO R, Maassen van den Brink A, Puledda F, Sandoe CH, et al
   Migraine management during pregnancy, breastfeeding and in women planning pregnancy.
   Cephalalgia. 2025;45:3331024251393945.
   PubMed         Abstract available
   
   
3. POZO-ROSICH P, Lopez JAG, Lisewski P, Aslan AN, et al
   A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications.
   Cephalalgia. 2025;45:3331024251391378.
   PubMed         Abstract available
   
   
4. ASHINA M, McAllister P, Gaul C, Leyva-Rendon A, et al
   Rimegepant for acute treatment of migraine in triptan-unsuitable adults: A randomized, double-blind, placebo-controlled phase 4 trial.
   Cephalalgia. 2025;45:3331024251395298.
   PubMed         Abstract available
   
   
5. TANG Y, Li H, Dong B, Sha L, et al
   Divergent functional connectivity patterns in menstrually-related and non-menstrual migraine: A large-scale resting-state fMRI study.
   Cephalalgia. 2025;45:3331024251396102.
   PubMed         Abstract available
   
   

   
   Headache

6. FERNANDEZ-BRAVO-RODRIGO J, Pascual-Morena C, Saz-Lara A, Martinez-Garcia I, et al
   Real-world effectiveness and safety of galcanezumab for the treatment of migraine: A systematic review and meta-analysis.
   Headache. 2025 Nov 17. doi: 10.1111/head.70003.
   PubMed         Abstract available
   
   
7. KITAMURA S, Matsumori Y, Yamamoto T, Ishikawa T, et al
   Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial.
   Headache. 2025 Nov 17. doi: 10.1111/head.15095.
   PubMed        
   
   
8. CHAUDHRY BA, Christensen RH, Ashina H, Al-Khazali HM, et al
   No differences in subcortical volume between people with and without migraine: A REFORM study.
   Headache. 2025 Nov 14. doi: 10.1111/head.70001.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

9. 
   Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
   Lancet Neurol. 2025;24:1005-1015.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.